HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 01-20-2009, 08:13 PM   #1
madubois63
Senior Member
 
madubois63's Avatar
 
Join Date: Feb 2005
Location: LI, NY
Posts: 660
Talking Experimental Breast Cancer Vaccine

Clinical Trials Of Experimental Breast Cancer Vaccine Expected To Begin In Spring

Main Category: Breast Cancer
Also Included In: Clinical Trials / Drug Trials; Immune System / Vaccines
Article Date: 07 Jan 2009 - 2:00 PST

Scientists from the University of Arkansas for Medical Sciences this spring expect to begin the first of two phases of clinical trials for a vaccine designed to prevent the recurrence of breast cancer, the AP/FoxNews.com reports. Principal investigator Laura Hutchins -- professor of internal medicine and director of the division of hematology and oncology at the university -- said that the vaccine, if successful, would not replace chemotherapy and radiation but could be an additional treatment for women with breast cancer. While working under a six-year, $2.9 million grant from the Department of Defense, a team from the Winthrop P. Rockefeller Cancer Institute at UAMS developed peptide antigens that mimic the carbohydrate antigens present on breast cancer cells. Although carbohydrate antigens do not typically stimulate a strong immune system response, the peptide-based vaccine is able to trick the body into producing antibodies that attack both the peptide antigens and carbohydrate antigens on the cancer cells, according to the AP/FoxNews.com.

The first phase of the clinical trials will involve women who have breast cancer that is actively spreading and women who had a recurrence after remission. Participants will receive five doses of the vaccine over four to six months. The second phase, which will last about one year, will involve women who are in remission, considered at high risk for a recurrence and have been off chemotherapy for at least six months. The number of women who will participate in the trials has not been determined. According to the latest data from CDC, 40,954 women died of breast cancer in the U.S. in 2004 (AP/FoxNews.com, 1/5).

Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.

© 2008 The Advisory Board Company. All rights reserved.
__________________
Maryann
Stage IV Inflammatory BC 1/00
Mod Rad Mastectomy 24nod/5+
Adriomycin Cytoxin Taxol
Tamoxifen 4 1/2 yrs
Radiation - 32 x
Metastatic BC lung/liver 10/04
thorocentesis 2x - pleurodesis
Herceptin Taxatiere Carbo
Femera/Lupron
BC NED 4/05
chemo induced Acute Myeloid Leukemia 5/06
Induction/consolidation chemo
bone marrow transplant - 11/3/06
Severe Host vs Graft Disease of liver
BC mets to lung 11/07
Fasoladex Herceptin Zometa Xeloda
GVHD/Iron overload to liver
Avascular Necrosis/morphine pump 10/10
metastatic brain tumor
steriotactic radiosurgery
madubois63 is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 02:17 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter